Skip to nav Skip to content
Alice  Yu

Alice Yu, MD

4.9 (313)

Specialty: Urology

Program: Genitourinary Oncology

Language(s): English

  • Overview

    Cancer Focus:
    Bladder Cancer, Kidney (Renal Cell) Cancer, Penile Cancer, Prostate Cancer, Testicular Cancer

    Dr. Yu received her MD from McGill University in Montreal, Quebec, Canada. She completed a Urology Residency at the McGill University Health Center. Subsequently, she spent two years in Boston, Massachusetts where she completed a Urologic Oncology Fellowship in the Combined Harvard Program at Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Yu’s clinical practice focuses on the surgical treatment of urologic cancers including prostate, bladder, kidney, penile and testicular cancer, using minimally invasive (laparoscopic and robotic) and open techniques. She is interested in surgical outcomes research and quality improvement with a focus on bladder and prostate cancers.

    Education & Training


    • Massachusetts General Hospital Brigham and Women's Hospital - Urologic Oncology
    • Massachusetts General Hospital Brigham and Women’s Hospital - Society of Urologic Oncology


    • McGill University Health Center - Urology

    Medical School:

    • McGill University - MD
  • Publications

    • Nicaise E, Feldman AS, Gusev A, Yu A, Nimmagadda N, Wszolek MF, McGovern F, Blute ML, Dahl DM. A contemporary comparison of laparoscopic versus open partial nephrectomy for renal cell carcinoma. BMC Urol. 2024 Mar.24(1):58. Pubmedid: 38475808. Pmcid: PMC10929101.
    • Tosoian JJ, Yu A, Brisbane WG. Point of View: Innovation and Progress for Screening and Management of Localized Prostate Cancer: What an Exciting Time. J Urol. 2024 Feb.211(2):317-319. Pubmedid: 38010955.
    • Davaro F, Davaro E, Rose K, Murthy P, Naidu S, Camperlengo L, Grass GD, Vosoughi A, Jain RK, Zemp L, Yu A, Poch MA, Spiess PE, Gilbert SM, Sexton WJ, Li R. Impact of surgical margin and extent of lymphadenectomy on oncologic outcomes in plasmacytoid urothelial carcinoma. Urol Oncol. 2023 Sep.41(9):389.e7-389.e13. Pubmedid: 36959058.
    • Li R, Naidu S, Fan W, Rose K, Huelster H, Grass GD, Vosoughi A, Dhillon J, Kim Y, Gupta S, Jain RK, Zhang J, Zemp L, Yu A, Poch MA, Spiess PE, Pow-Sang J, Gilbert SM, Sexton WJ. Effectiveness of perioperative chemotherapy and radical cystectomy in treating bladder cancer. Urol Oncol. 2023 Nov.41(11):457.e17-457.e24. Pubmedid: 37880002.
    • Murthy PB, Naidu S, Davaro F, Spiess PE, Zemp L, Poch M, Jain R, Vosoughi A, Grass GD, Yu A, Sexton WJ, Gilbert SM, Li R. Survival Benefits of Adjuvant Chemotherapy for Positive Soft Tissue Surgical Margins Following Radical Cystectomy in Bladder Cancer with Extravesical Extension. Curr Oncol. 2023 Mar.30(3):3223-3231. Pubmedid: 36975458. Pmcid: PMC10046994.
    • Moses KA, Sprenkle PC, Bahler C, Box G, Carlsson SV, Catalona WJ, Dahl DM, Dall'Era M, Davis JW, Drake BF, Epstein JI, Etzioni RB, Farrington TA, Garraway IP, Jarrard D, Kauffman E, Kaye D, Kibel AS, LaGrange CA, Maroni P, Ponsky L, Reys B, Salami SS, Sanchez A, Seibert TM, Shaneyfelt TM, Smaldone MC, Sonn G, Tyson MD, Vapiwala N, Wake R, Washington S, Yu A, Yuh B, Berardi RA, Freedman-Cass DA. NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023. J Natl Compr Canc Ne. 2023 Mar.21(3):236-246. Pubmedid: 36898362.
    • Fink AKC, DeRenzis AC, Awasthi S, Jahan N, Johnstone PAS, Pow-Sang J, Torres-Roca J, Grass D, Fernandez D, Naghavi A, Tan S, Manley B, Li R, Poch M, Yu A, Little N, Bass E, Ercole CE, Katsoulakis E, Burri R, Smith R, Stanley NB, Vadaparampil ST, Yamoah K. Identifying and overcoming barriers to participation of minority populations in clinical trials: Lessons learned from the VanDAAM study. Cancer Med. 2023 Jan.12(2):1869-1877. Pubmedid: 35796421. Pmcid: PMC9883445.
    • Yu A, Chahoud J, Necchi A, Spiess PE. The Evolving Landscape of Viral, Immune, and Molecular Biomarkers in Penile Cancer. Urol Clin North Am. 2023 Feb.50(1):145-150. Pubmedid: 36424078.
    • Rose KM, Narang G, Rosen G, Labatte C, Dumitrascu C, Campagna J, Yu A, Manley BJ, Spiess PE, Li R, Adibi M, Murray KS, Sexton WJ, Humphreys MR. Antegrade administration of mitomycin gel for upper tract urothelial carcinoma via percutaneous nephrostomy tube: a multi-institutional retrospective cohort study. BJU Int. 2023 Apr.131(4):471-476. Pubmedid: 36285629.
    • Aydin AM, Cheriyan SK, Reich R, Hajiran A, Peyton CC, Zemp L, Yu A, Li R, Poch MA, Spiess PE, Jain R, Zhang J, Sexton WJ, Gilbert SM. Comparative analysis of three vs. four cycles of neoadjuvant gemcitabine and cisplatin for muscle invasive bladder cancer. Urol Oncol. 2022 Oct.40(10):453.e19-453.e26. Pubmedid: 35811208.
    • Yu A, Yamany T, Mojtahed A, Hanna N, Nicaise E, Harisinghani M, Wu CL, Dahl DM, Wszolek M, Blute ML, Feldman AS. Combination MRI-targeted and systematic prostate biopsy may overestimate gleason grade on final surgical pathology and impact risk stratification. Urol Oncol. 2022 Feb.40(2):59.e1-59.e5. Pubmedid: 34544650.
    • Rishi A, Saini AS, Spiess PE, Yu A, Fernandez DC, Johnstone PAS, Naghavi AO. Novel portable apparatus for outpatient high-dose-rate (HDR) brachytherapy in penile cancer. Brachytherapy. 2022 Aug.21(6):839-847. Pubmedid: 35915039.
    • Kumar NB, Hogue S, Pow-Sang J, Poch M, Manley BJ, Li R, Dhillon J, Yu A, Byrd DA. Effects of Green Tea Catechins on Prostate Cancer Chemoprevention: The Role of the Gut Microbiome. Cancers (Basel). 2022 Aug.14(16). Pubmedid: 36010981. Pmcid: PMC9406482.
    • Aydin AM, Reich RR, Cao B, Cheriyan SK, Hajiran A, Zemp L, Yu A, Poch MA, Sexton WJ, Li R, Gilbert SM. Clinical indications for necessary and discretionary hospital readmissions after radical cystectomy. Urol Oncol. 2022 Apr.40(4):164.e1-164.e7. Pubmedid: 34629281. Pmcid: PMC8960322.
    • Yu A, Wang Y, Mossanen M, Preston M, Carvalho FL, Chung BI, Chang SL. Robotic-assisted radical cystectomy is associated with lower perioperative mortality in octogenarians. Urol Oncol. 2022 Apr.40(4):163.e19-163.e23. Pubmedid: 34602361.
    • Chakiryan N, Yu A. Editorial Comment. J Urol. 2021 Sep.206(3):575-576. Pubmedid: 34105989.
    • Yu A, Cooke AB, Scheffler P, Doonan RJ, Daskalopoulou SS. Alcohol Exerts a Shifted U-Shaped Effect on Central Blood Pressure in Young Adults. J Gen Intern Med. 2021 Oct.36(10):2975-2981. Pubmedid: 33674917. Pmcid: PMC8481396.
    • Yu A, Zlatev DV, Blute ML. Revisiting the role of lymph node dissection in renal cell carcinoma. Ann Transl Med. 2019 Jul.7(Suppl 3):S91. Pubmedid: 31576299. Pmcid: PMC6685843.
    • Yu A, Mansure JJ, Solanki S, Siemens DR, Koti M, Dias ABT, Burnier MM, Brimo F, Kassouf W. Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as prognostic marker in patients after radical cystectomy. PLoS One. 2018 Oct.13(10):e0205746. Pubmedid: 30308033. Pmcid: PMC6181418.
    • Yu A, Capolicchio JP. A case of epidermoid median raphe cyst traversing the corpora cavernosa. Can Urol Assoc J. 2017 Mar.11(3-4):E119-E121. Pubmedid: 28360959. Pmcid: PMC5365388.
    • Yu A, Campeau L. Bone marrow mesenchymal stem cell therapy for voiding dysfunction. Curr Urol Rep. 2015 Jul.16(7):49. Pubmedid: 26025492.
    • Elkoushy MA, Yu AX, Tabah R, Payne RJ, Dragomir A, Andonian S. Determinants of urolithiasis before and after parathyroidectomy in patients with primary hyperparathyroidism. Urology. 2014 Jul.84(1):22-26. Pubmedid: 24703459.
    • Yu A, Giannone T, Scheffler P, Doonan RJ, Egiziano G, Gomez YH, Papaioannou TG, Daskalopoulou SS. The effect of oral contraceptive pills and the natural menstrual cYCLe on arterial stiffness and hemodynamICs (CYCLIC). J Hypertens. 2014 Jan.32(1):100-107. Pubmedid: 24326993.
    • Scheffler P, Muccio S, Egiziano G, Doonan RJ, Yu A, Carli F, Daskalopoulou SS. Heart rate variability exhibits complication-dependent changes postsurgery. Angiology. 2013 Nov.64(8):597-603. Pubmedid: 23091271.
    • Yu A, Shahrour W, Andonian S. Simultaneous bilateral tubeless percutaneous nephrolithotomy: A report of 2 cases and review of the literature. Can Urol Assoc J. 2012 Aug.6(4):E162-E166. Pubmedid: 23093570. Pmcid: PMC3430725.
    • Doonan RJ, Scheffler P, Yu A, Egiziano G, Mutter A, Bacon S, Carli F, Daskalopoulos ME, Daskalopoulou SS. Altered arterial stiffness and subendocardial viability ratio in young healthy light smokers after acute exercise. PLoS One. 2011 Oct.6(10):e26151. Pubmedid: 22028821. Pmcid: PMC3189960.
  • Patient Comments

    Overall Satisfaction


    313 patients rated this provider

    The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.

    Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

    Learn more about our patient satisfaction survey



    Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

    We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

    Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.

    Learn more about our patient comments

    Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:

    • The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
    • He or she may be a researcher or other type of provider that does not see patients.
    • The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.

    Learn more about our patient satisfaction survey, ratings and comments

Find a Doctor